跳至主要内容
临床试验/ACTRN12616001649404
ACTRN12616001649404撤回4 期

Correlation study of polymorphisms in genes SLC7A5 and SLC22A4 with the pregabalin efficacy and safety in patients with chronic low back pain.

Aristotle University of Thessaloniki, Greece0 个研究点目标入组 200 人开始时间: 2016年11月29日最近更新:

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 79 Years(—)
性别
All

入选标准

  • 1.Age 18-79 years
  • 2.Patients with lumbar radicular pain for more than three months
  • 3.Patients with disc prolapse, spinal stenosis or failed surgery in the lumbar spine
  • 4.Patients with neuropathic pain which is certified both by the discovery of nerve damage points as weakness, numbness, hyperalgesia, allodynia and with a NRS score larger that 4/10.

排除标准

  • 1. Pain in the lumbar region stronger than the radicular pain
  • 2. Significant motor deficits / disorders in urine bladder or bowel
  • 3. Known depression with or without antidepressant treatment
  • 4. Background of addiction or abuse
  • 5. Current treatment with gabapentin, pregabalin or opioids
  • 6. Diabetic or postherpetic neuropathy
  • 7. Renal insufficiency, diabetes, congestive heart failure, thrombocytopenia.
  • 8. Use of ACE inhibitors

研究者

发起方
Aristotle University of Thessaloniki, Greece

相似试验